OPERF
ALXN

Oregon Public Employees Retirement Fund’s Alexion Pharmaceuticals ALXN Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-81,056
Closed -$14.9M – 1587
2021
Q2 		$14.9M Buy
81,056
+23,950
+42% +$4.11M 0.17% 111
2021
Q1 		$8.73M Buy
57,106
+1,152
+2% +$178K 0.1% 187
2020
Q4 		$8.74M Buy
55,954
+6,518
+13% +$838K 0.11% 175
2020
Q3 		$5.66M Sell
49,436
-3,600
-7% -$388K 0.08% 214
2020
Q2 		$5.95M Buy
53,036
+32,100
+153% +$3.41M 0.09% 211
2020
Q1 		$1.88M Sell
20,936
-415
-2% -$40.7K 0.03% 451
2019
Q4 		$2.31M Sell
21,351
-1,245
-6% -$133K 0.03% 511
2019
Q3 		$2.21M Sell
22,596
-1,145
-5% -$129K 0.03% 581
2019
Q2 		$3.11M Buy
23,741
+139
+0.6% +$17.9K 0.04% 441
2019
Q1 		$3.19M Sell
23,602
-619
-3% -$77K 0.05% 396
2018
Q4 		$2.36M Sell
24,221
-173
-0.7% -$20.4K 0.04% 467
2018
Q3 		$3.39M Buy
24,394
+404
+2% +$50.7K 0.05% 398
2018
Q2 		$2.98M Buy
23,990
+190
+0.8% +$22.2K 0.04% 433
2018
Q1 		$2.65M Buy
23,800
+47
+0.2% +$5.62K 0.04% 473
2017
Q4 		$2.84M Hold
23,753
– – 0.04% 448
2017
Q3 		$3.33M Buy
23,753
+129
+0.5% +$17.5K 0.05% 389
2017
Q2 		$2.87M Buy
23,624
+200
+0.9% +$23.3K 0.05% 425
2017
Q1 		$2.84M Hold
23,424
– – 0.06% 355
2016
Q4 		$2.87M Buy
23,424
+261
+1% +$31.9K 0.06% 342
2016
Q3 		$2.84M Sell
23,163
-780
-3% -$100K 0.06% 323
2016
Q2 		$2.8M Sell
23,943
-600
-2% -$85.1K 0.06% 336
2016
Q1 		$3.42M Buy
24,543
+725
+3% +$106K 0.08% 258
2015
Q4 		$4.54M Sell
23,818
-8,500
-26% -$1.48M 0.11% 176
2015
Q3 		$5.05M Buy
32,318
+1,200
+4% +$219K 0.13% 157
2015
Q2 		$5.63M Buy
31,118
+3,800
+14% +$656K 0.13% 151
2015
Q1 		$4.73M Buy
27,318
+400
+1% +$72.4K 0.11% 187
2014
Q4 		$4.98M Sell
26,918
-3,852
-13% -$714K 0.12% 175
2014
Q3 		$5.1M Buy
30,770
+300
+1% +$49.3K 0.13% 165
2014
Q2 		$4.76M Buy
30,470
+11,600
+61% +$1.83M 0.12% 176
2014
Q1 		$2.87M Buy
18,870
+100
+0.5% +$15.9K 0.08% 275
2013
Q4 		$2.5M Buy
18,770
+400
+2% +$48K 0.07% 307
2013
Q3 		$2.13M Buy
18,370
+83
+0.5% +$9.11K 0.09% 242
2013
Q2 		$1.69M Buy
+18,287
New +$1.76M 0.07% 292

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ALXN Position: Q3 2021 in Review

Oregon Public Employees Retirement Fund sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 81,056 shares — an estimated $14.9M sold.

Oregon Public Employees Retirement Fund first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $14.9M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Oregon Public Employees Retirement Fund reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 81,056 Alexion Pharmaceuticals shares in Q3 2021, an estimated $14.9M.
  • Oregon Public Employees Retirement Fund first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Oregon Public Employees Retirement Fund's Alexion Pharmaceuticals position peaked at $14.9M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q3 2021, filed 19 Oct 2021.